Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 9, 2011, Pages 1908-1918

  Wolf, Robert C ^a,b   Grön, Georg ^b   Sambataro, Fabio ^c   Vasic, Nenad ^b   Wolf, Nadine D ^d   Thomann, Philipp A ^a   Saft, Carsten ^e   Landwehrmeyer, G Bernhard ^b   Orth, Michael ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^e ST JOSEF HOSPITAL   (Germany)

Author keywords

Arterial spin labeling; cerebral blood flow; Huntington's disease; magnetic resonance imaging; prefrontal cortex; striatum

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE FRONTAL GYRUS; NEUROIMAGING; ONSET AGE; PERFUSION WEIGHTED IMAGING; PRECUNEUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SENSITIVITY ANALYSIS; SPIN LABELING; VOXEL BASED MORPHOMETRY;

ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEURONS;

EID: 80052407852     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.60     Document Type: Article

References (44)

1. Amos A (2000) A computational model of information processing in the frontal cortex and basal ganglia. J Cogn Neurosci 12:505-19 (Pubitemid 30410289)
2. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods. Neuroimage 11:805-21
3. Aylward EH (2007) Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Res Bull 72:152-8 (Pubitemid 46367460)
4. Brandt J, Inscore AB, Ward J, Shpritz B, Rosenblatt A, Margolis RL, Ross CA (2008) Neuropsychological deficits in Huntington's disease gene carriers and correlates of early 'conversion'. J Neuropsychiatry Clin Neurosci 20:466-72
5. Brett M, Anton J-L, Valabregue R, Poline J-B (2002) Region of interest analysis using an SPM toolbox. Neuroimage 16(2): abstract 497 (available on CD-ROM)
6. Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, Squitieri F (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 47:215-22 (Pubitemid 46780885)
7. Correa N, Adali T, Yi-Ou L, Calhoun VD (2005) Comparison of blind source separation algorithms for FMRI using a new Matlab toolbox: GIFT. Proc IEEE Int Conf Acoustics, Speech, Signal Processing 5:401-4
8. Deckel AW, Tang V, Nuttal D, Gary K, Elder R (2002) Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice. Brain Res 939:76-86 (Pubitemid 34518591)
9. Detre JA, Wang J (2002) Technical aspects and utility of fMRI using BOLD and ASL. Clin Neurophysiol 113: 621-34 (Pubitemid 34439266)
10. DiProspero NA, Chen EY, Charles V, Plomann M, Kordower JH, Tagle DA (2004) Early changes in Huntington's disease patient brains involve alterations in cyto-skeletal and synaptic elements. J Neurocytol 33: 517-33 (Pubitemid 40768575)
11. Eidelberg D (2009) Metabolic brain networks in neuro-degenerative disorders: a functional imaging approach. Trends Neurosci 32:548-57
12. Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, Paulsen JS, Dhawan V, Eidelberg D (2007) Thalamic metabolism and symptom onset in preclinical Hunting-ton's disease. Brain 130:2858-67 (Pubitemid 350033965)
13. Feigin AS, Ghilardi MF, Huang C, Yilong M, Carbon M, Guttman M, Paulsen JS, Ghez CP, Eidelberg D (2006) Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol 59:53-9 (Pubitemid 43042871)
14. Floyd TF, Ratcliffe SJ, Wang J, Resch B, Detre JA (2003) Precision of the CASL-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories. J Magn Reson Imaging 18: 649-55 (Pubitemid 37467265)
15. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19: 2522-34 (Pubitemid 29162401)
16. Harris GJ, Codori AM, Lewis RF, Schmidt E, Bedi A, Brandt J (1999) Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain 122(Part 9):1667-78 (Pubitemid 29425670)
17. Hasselbalch SG, Oberg G, Sorensen SA, Andersen AR, Waldemar G, Schmidt JF, Fenger K, Paulson OB (1992) Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J Neurol Neurosurg Psychiatry 55:1018-23
18. Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ (2010) The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study. J Neurol Neurosurg Psychiatry 81:756-63
19. Huntington-Study-Group (1996) Unified Huntington's Disease Rating Scale: reliability and consistency. Movement Disorders 11:136-42
20. Kloppel S, Draganski B, Siebner HR, Tabrizi SJ, Weiller C, Frackowiak RS (2009a) Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 132:1624-32
21. Kloppel S, Henley SM, Hobbs NZ, Wolf RC, Kassubek J, Tabrizi SJ, Frackowiak RS (2009b) Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience 164:205-19
22. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR (2004) A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 65:267-77 (Pubitemid 38443548)
23. Li YO, Adali T, Calhoun VD (2007) Estimating the number of independent components for functional magnetic resonance imaging data. Hum Brain Mapp 28: 1251-66 (Pubitemid 350077488)
24. Maitra R (2009) Assessing certainty of activation or inactivation in test-retest fMRI studies. Neuroimage 47:88-97
25. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitec-tonic atlas-based interrogation of fMRI data sets. Neuro-image 19:1233-9 (Pubitemid 36918259)
26. Monchi O, Petrides M, Petre V, Worsley K, Dagher A (2001) Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 21:7733-41 (Pubitemid 32904972)
27. Paulsen JS (2009) Functional imaging in Huntington's disease. Exp Neurol 216:272-7
28. Paulsen JS, Zimbelman JL, Hinton SC, Langbehn DR, Leveroni CL, Benjamin ML, Reynolds NC, Rao SM (2004) fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. Am J Neuro-radiol 25:1715-21 (Pubitemid 44123696)
29. Petersen ET, Mouridsen K, Golay X (2010) The QUASAR reproducibility study, Part II: results from a multi-center arterial spin labeling test-retest study. Neuroimage 49:104-13
30. Rajah MN, D'Esposito M (2005) Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory. Brain 128:1964-83 (Pubitemid 41253265)
31. Saft C, Kosinski CM, Landwehrmeyer B (2009) [Progress in premanifest and manifest diagnostics in Huntington's disease.]. Aktuelle Neurologie 36:506-23
32. Spitzer M, Franke B, Walter H, Buechler J, Wunderlich AP, Schwab M, Kovar K, Hermle L, Gron G (2001) Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans. Neuropharmacology 41:263-71 (Pubitemid 32728098)
33. Stocker T, Schneider F, Klein M, Habel U, Kellermann T, Zilles K, Shah NJ (2005) Automated quality assurance routines for fMRI data applied to a multicenter study. Hum Brain Mapp 25:237-46 (Pubitemid 40734090)
34. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC (2009) Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8: 791-801
35. Talairach J, Tournoux P (1988) Co-Planar Stereotaxic Atlas of the Human Brain. New York, NY: Thieme Medical Publishers
36. Voermans NC, Petersson KM, Daudey L, Weber B, Van Spaendonck KP, Kremer HP, Fernandez G (2004) Interaction between the human hippocampus and the caudate nucleus during route recognition. Neuron 43:427-35 (Pubitemid 39061133)
37. Vonsattel JP, Myers RH, Stevens TJ (1985) Neuropatho-logical classification of Huntington's disease. J Neuro-pathol Exp Neurol 44:559-77
38. Wang J, Aguirre GK, Kimberg DY, Detre JA (2003) Empirical analyses of null-hypothesis perfusion FMRI data at 1.5 and 4 T. Neuroimage 19:1449-62 (Pubitemid 37025844)
39. Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA (2005) Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study. Radiology 235:218-28 (Pubitemid 40432258)
40. Wolf RC, Sambataro F, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer B (2008a) Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol 213:137-44
41. Wolf RC, Sambataro F, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer B (2008b) Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load. Eur J Neurol 15:1180-90
42. Wolf RC, Vasic N, Schonfeldt-Lecuona C, Landwehrmeyer GB, Ecker D (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 130:2845-57 (Pubitemid 350033962)
43. Zimbelman JL, Paulsen JS, Mikos AE, Reynolds NC, Hoffman RG, Rao SM (2007) fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int NeuropsycholSoc 13:758-69 (Pubitemid 47299445)
44. Zimmermann P, Fimm B (1994) Testbatterie zur Aufmerk-samkeitsprüfung (TAP). Herzogenrath: Psytest